(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
-7.95% $ 1.620
@ $2.25
Wydano: 14 vas. 2024 @ 16:30
Zwrot: -28.00%
Poprzedni sygnał: vas. 13 - 21:04
Poprzedni sygnał:
Zwrot: 5.14 %
Live Chart Being Loaded With Signals
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety...
Stats | |
---|---|
Dzisiejszy wolumen | 2.48M |
Średni wolumen | 1.56M |
Kapitalizacja rynkowa | 293.68M |
EPS | $0 ( 2024-05-02 ) |
Następna data zysków | ( $-0.0500 ) 2024-06-05 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.71 |
ATR14 | $0.00700 (0.43%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-12 | Green Kevin Dennis | Buy | 21 666 | Common Stock |
2024-03-13 | Green Kevin Dennis | Sell | 21 058 | Common Stock |
2024-03-14 | Green Kevin Dennis | Sell | 21 497 | Common Stock |
2024-03-12 | Green Kevin Dennis | Sell | 21 666 | Restricted Stock Unit |
2024-03-12 | Moore Carol | Buy | 11 666 | Common Stock |
INSIDER POWER |
---|
53.72 |
Last 100 transactions |
Buy: 4 007 373 | Sell: 1 157 608 |
Wolumen Korelacja
Cerus Corp Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
RGCO | 0.924 |
DCRC | 0.918 |
ASPS | 0.912 |
VIEW | 0.904 |
TIGR | 0.903 |
LGHL | 0.903 |
SFIX | 0.899 |
VIASP | 0.898 |
OP | 0.897 |
LKFN | 0.895 |
10 Najbardziej negatywne korelacje | |
---|---|
ARIZ | -0.918 |
PEP | -0.916 |
LBPH | -0.915 |
TWCB | -0.911 |
GLLI | -0.91 |
XPDB | -0.909 |
AVAC | -0.909 |
HWEL | -0.904 |
MDLZ | -0.903 |
PUCK | -0.901 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cerus Corp Korelacja - Waluta/Towar
Cerus Corp Finanse
Annual | 2023 |
Przychody: | $156.37M |
Zysk brutto: | $84.00M (53.72 %) |
EPS: | $-0.210 |
FY | 2023 |
Przychody: | $156.37M |
Zysk brutto: | $84.00M (53.72 %) |
EPS: | $-0.210 |
FY | 2022 |
Przychody: | $162.05M |
Zysk brutto: | $87.09M (53.75 %) |
EPS: | $-0.240 |
FY | 2021 |
Przychody: | $159.52M |
Zysk brutto: | $96.04M (60.21 %) |
EPS: | $-0.316 |
Financial Reports:
No articles found.
Cerus Corp
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej